Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase
- 17 August 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (18), 10460-10473
- https://doi.org/10.1021/acs.jmedchem.0c01125
Abstract
We report the first disclosure of IRAK3 degraders in the scientific literature. Taking advantage of an opportune by-product obtained during our efforts to identify IRAK4 inhibitors, we identified ready to use, selective IRAK3 ligands in our compound collection with the required properties for conversion into PROTAC degraders. This work culminated with the discovery of PROTAC 23, which we demonstrated to be a potent and selective degrader of IRAK3. 23 induced proteasome-dependent degradation of IRAK3 and required both CRBN and IRAK3 binding for activity. We conclude that PROTAC 23 constitutes an excellent in vitro tool with which to interrogate the biology of IRAK3.Keywords
This publication has 20 references indexed in Scilit:
- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological DiscoveryCell, 2020
- IRAK family in inflammatory autoimmune diseasesAutoimmunity Reviews, 2020
- Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune ResponsesMolecular Therapy, 2019
- Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challengesBioorganic & Medicinal Chemistry Letters, 2019
- Prospects for pharmacological targeting of pseudokinasesNature Reviews Drug Discovery, 2019
- Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and PiperazinesJournal of Medicinal Chemistry, 2018
- Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell LymphomaJournal of Medicinal Chemistry, 2017
- IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3Cancer Cell, 2016
- IRAK signalling in cancerBritish Journal of Cancer, 2014
- IRAK-M Is a Negative Regulator of Toll-like Receptor SignalingCell, 2002